These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4033071)

  • 21. Immunoassay method validation for a modified EMIT phencyclidine assay.
    Cary PL; Johnson CA; Folsom TM; Bales WR
    J Anal Toxicol; 1992; 16(1):48-51. PubMed ID: 1640698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry.
    Fitzgerald RL; Rexin DA; Herold DA
    Clin Chem; 1994 Mar; 40(3):373-80. PubMed ID: 8131270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
    McBurney LJ; Bobbie BA; Sepp LA
    J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High urinary cannabinoids from a hashish body packer.
    Meatherall RC; Warren RJ
    J Anal Toxicol; 1993; 17(7):439-40. PubMed ID: 8309221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative results with five cannabinoid immunoassay systems at the screening threshold of 100 micrograms/L.
    Wells DJ; Barnhill MT
    Clin Chem; 1989 Nov; 35(11):2241-3. PubMed ID: 2582623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laboratory evaluation of immunoassay kits for the detection of cannabinoids in biological fluids.
    Peat MA; Finkle BS; Deyman ME
    NIDA Res Monogr; 1982; 42():85-98. PubMed ID: 6817140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EMIT cannabinoid assay: confirmation by RIA and GC/MS.
    O'Connor JE; Rejent TA
    J Anal Toxicol; 1981; 5(4):168-73. PubMed ID: 7024638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay.
    Fraser AD
    J Anal Toxicol; 1987; 11(6):263-6. PubMed ID: 3323671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Abbott fluorescence polarization immunoassay (FPIA) and Roche radioimmunoassay for the analyses of cannabinoids in urine specimens.
    Budgett WT; Levine B; Xu A; Smith ML
    J Forensic Sci; 1992 Mar; 37(2):632-5. PubMed ID: 1500902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory evaluation of the TDx assay for detection of cannabinoids in urine from prison inmates.
    Karlsson L; Ström M
    J Anal Toxicol; 1988; 12(6):319-21. PubMed ID: 3072448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids.
    Spinelli E; Barnes AJ; Young S; Castaneto MS; Martin TM; Klette KL; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):467-74. PubMed ID: 25167963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sensitive thin-layer chromatographic procedure for the detection of urinary 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid.
    Meatherall RC; Garriott JC
    J Anal Toxicol; 1988; 12(3):136-40. PubMed ID: 2838684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labetalol: false-positive indices by EMIT-d.a.u. assay and Toxi-Lab A urine screen.
    Apple FS; Googins MK; Kastner S; Nevala K; Edmondson S; Kloss J
    Clin Chem; 1985 Jul; 31(7):1250-1. PubMed ID: 3891145
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection and quantitation of cannabinoids in biological fluids: specificity and kinetics after smoking.
    Scherrmann JM; Hoellinger H; Nguyen-Hoang-Nam ; Boudet L; Pichon J; Do-Cao-Thang
    Clin Toxicol; 1981 May; 18(5):565-71. PubMed ID: 6268351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enzyme immunochemical detection of the use of hashish and confirmation by thin-layer chromatography].
    von Meyer L
    Z Rechtsmed; 1985; 94(3):219-25. PubMed ID: 2992188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method validation of the biochip array technology for synthetic cannabinoids detection in urine.
    Castaneto MS; Desrosiers NA; Ellefsen K; Anizan S; Martin TM; Klette KL; Huestis MA
    Bioanalysis; 2014; 6(21):2919-30. PubMed ID: 25486237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of a detection level of 25ng/mL for cannabinoids in urine using a CEDIA THCPLUS immunoassay: application of this cut-off to urines of school children.
    Madhavaram H; Couch RA
    Forensic Sci Int; 2010 May; 198(1-3):28-30. PubMed ID: 20219301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marijuana testing--how good is it?
    Moyer TP; Palmen MA; Johnson P; Charlson JR; Ellefson PJ
    Mayo Clin Proc; 1987 May; 62(5):413-7. PubMed ID: 3553756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.